Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
1.
Contact Dermatitis ; 79(5): 295-302, 2018 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-30094861

RESUMO

BACKGROUND: Contact allergy is common in children, but may be underdiagnosed. Importantly, the clinical relevance of specific allergies is subject to constant change, and it is therefore important to continuously monitor the trends and changes of contact allergies in the paediatric population. OBJECTIVES: To identify possible changes in contact allergy and allergic contact dermatitis among Danish children referred for patch testing. METHODS: A retrospective study was performed based on patch test data from the Danish National Database of Contact allergy. The current data were compared with previously published data on Danish children referred for patch testing. RESULTS: Between 2012 and 2016, 1573 children and adolescents were patch tested. Overall, 385 (24.5%) had at least 1 positive patch test reaction. The overall prevalence was similar in boys and girls, across age groups, and in patients with and without atopic dermatitis. Statistically significant increases in contact allergy to fragrances and isothiazoliones were seen, whereas a decrease in nickel allergy was found. CONCLUSION: Allergic contact dermatitis continues to be a common disease in children, and is even significantly increasing for some allergens.


Assuntos
Dermatite Alérgica de Contato/epidemiologia , Adolescente , Alérgenos/efeitos adversos , Criança , Pré-Escolar , Cobalto/efeitos adversos , Dinamarca/epidemiologia , Dermatite Alérgica de Contato/diagnóstico , Dermatite Alérgica de Contato/etiologia , Dermatite Atópica/diagnóstico , Dermatite Atópica/epidemiologia , Dermatite Atópica/etiologia , Feminino , Humanos , Lactente , Masculino , Níquel/efeitos adversos , Testes do Emplastro , Perfumes/efeitos adversos , Conservantes Farmacêuticos/efeitos adversos , Prevalência , Estudos Retrospectivos
5.
Clin Cosmet Investig Dermatol ; 11: 451-459, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-30349342

RESUMO

An aerosol foam formulation of a once-daily, fixed-dose combination of a synthetic vitamin D3 analog/synthetic corticosteroid (calcipotriol [Cal] 50 µg/g and betamethasone dipropionate [BD] 0.5 mg/g) has recently been introduced for the topical treatment of plaque psoriasis in adults. Data from several sources - randomized controlled trials, case reports (as highlighted in this review), and real-world evidence (RWE) - underscore the considerable and rapid clinical response, effectiveness, and favorable safety and tolerability of Cal/BD aerosol foam in mild-to-moderate psoriatic patients previously treated with class 3 or 4 topical corticosteroids, in patients unsatisfied with ongoing phototherapy in combination with topical therapy and in patients with moderate-to-severe psoriasis. In addition, our case series, considered together with other RWE, highlights that Cal/BD aerosol foam is more effective and with greater levels of patient preference and acceptability than comparator preparations. Thus, Cal/BD aerosol foam offers several treatment advantages, including relief of itch, and is an appropriate first-line topical therapy for consideration in patients with psoriasis of any severity.

6.
J Dermatolog Treat ; 29(1): 68-73, 2018 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-28658998

RESUMO

Topical treatments in dermatology can be long, complex and lead to nonadherence and nonpersistence to prescribed treatment. Clinical efficacy observed in randomized clinical trials (RCT) may therefore be reduced in real-world clinical practice. The objective of this study was to analyze patient-reported treatment adherence, treatment satisfaction and health-related quality of life (HRQoL) with topical treatments of actinic keratosis (AK) in routine clinical practice in Denmark and Sweden. Adult patients prescribed field-directed topical AK treatments with diclofenac gel, imiquimod or ingenol mebutate per routine clinical practice were eligible for the observational RAPID-ACT study. Data were collected through physician and patient questionnaires that included validated instruments to measure treatment satisfaction (TSQM-9), treatment adherence (MMAS) and HRQoL (EQ-5D-5L, EQ-VAS, AKQoL). In total, 446 patients from Denmark and Sweden were included. Ingenol mebutate patients reported a higher satisfaction with treatment effectiveness compared to patients treated with diclofenac (p = .006) while no other differences in treatment satisfaction could be determined. Treatment adherence was generally high, but higher for ingenol mebutate compared to both diclofenac (p < .001) and imiquimod (p = .007), possibly due to shorter treatment duration. No differences in improved HRQoL were found. More research is needed about the link between treatment adherence and real-world effectiveness.


Assuntos
Aminoquinolinas/uso terapêutico , Diclofenaco/uso terapêutico , Diterpenos/uso terapêutico , Ceratose Actínica/tratamento farmacológico , Administração Tópica , Idoso , Dinamarca , Esquema de Medicação , Feminino , Humanos , Imiquimode , Masculino , Pessoa de Meia-Idade , Medidas de Resultados Relatados pelo Paciente , Satisfação do Paciente , Qualidade de Vida , Inquéritos e Questionários , Suécia
7.
Clin Epidemiol ; 8: 633-636, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-27822110

RESUMO

AIM OF DATABASE: The Danish Nonmelanoma Skin Cancer Dermatology Database was established in 2008. The aim of this database was to collect data on nonmelanoma skin cancer (NMSC) treatment and improve its treatment in Denmark. NMSC is the most common malignancy in the western countries and represents a significant challenge in terms of public health management and health care costs. However, high-quality epidemiological and treatment data on NMSC are sparse. STUDY POPULATION: The NMSC database includes patients with the following skin tumors: basal cell carcinoma (BCC), squamous cell carcinoma, Bowen's disease, and keratoacanthoma diagnosed by the participating office-based dermatologists in Denmark. MAIN VARIABLES: Clinical and histological diagnoses, BCC subtype, localization, size, skin cancer history, skin phototype, and evidence of metastases and treatment modality are the main variables in the NMSC database. Information on recurrence, cosmetic results, and complications are registered at two follow-up visits at 3 months (between 0 and 6 months) and 12 months (between 6 and 15 months) after treatment. DESCRIPTIVE DATA: In 2014, 11,522 patients with 17,575 tumors were registered in the database. Of tumors with a histological diagnosis, 13,571 were BCCs, 840 squamous cell carcinomas, 504 Bowen's disease, and 173 keratoakanthomas. CONCLUSION: The NMSC database encompasses detailed information on the type of tumor, a variety of prognostic factors, treatment modalities, and outcomes after treatment. The database has revealed that overall, the quality of care of NMSC in Danish dermatological clinics is high, and the database provides the necessary data for continuous quality assurance.

9.
Ugeskr Laeger ; 172(23): 1765-6, 2010 Jun 07.
Artigo em Dinamarquês | MEDLINE | ID: mdl-20534207

RESUMO

Differentiation between infectious and non-infectious cellulitis is a frequent clinical issue. Often, there is no proven portal of entry for infection and it is difficult to obtain a positive culture. Two case stories with recurrence of postoperative cellulitis are presented. Lymphoedema, often seen post surgery, is itself inflammatory and may cause inflammatory cellulitis. In recurrent cases of cellulitis without any effect of antibiotic treatment, inflammatory cellulitis should be considered.


Assuntos
Doenças Mamárias/diagnóstico , Mama/patologia , Celulite (Flegmão)/etiologia , Complicações Pós-Operatórias/etiologia , Doenças Mamárias/etiologia , Doenças Mamárias/patologia , Neoplasias da Mama/cirurgia , Carcinoma Ductal de Mama/cirurgia , Celulite (Flegmão)/patologia , Diagnóstico Diferencial , Feminino , Humanos , Melanoma/cirurgia , Pessoa de Meia-Idade , Complicações Pós-Operatórias/patologia , Recidiva
10.
Dermatitis ; 21(2): E7-10, 2010.
Artigo em Inglês | MEDLINE | ID: mdl-20233542

RESUMO

Allergic contact dermatitis (ACD) from salicylates present in topical products is uncommon. Most publications about ACD from salicylates are case reports describing only a few patients. Cross-reactivity between salicylates is not commonly reported. This article describes allergic contact dermatitis from ethylhexyl salicylate used as an ultraviolet filter and fragrance compound and reviews the published literature on contact allergy to salicylates.


Assuntos
Dermatite Alérgica de Contato/diagnóstico , Dermatite Alérgica de Contato/etiologia , Hipersensibilidade a Drogas/diagnóstico , Hipersensibilidade a Drogas/etiologia , Perfumes/efeitos adversos , Salicilatos/efeitos adversos , Protetores Solares/efeitos adversos , Administração Tópica , Feminino , Humanos , Pessoa de Meia-Idade , Testes do Emplastro , Perfumes/administração & dosagem , Salicilatos/administração & dosagem , Protetores Solares/administração & dosagem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA